These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3475538)

  • 21. Effect of aspirin desensitization on T-cell cytokines and plasma lipoxins in aspirin-exacerbated respiratory disease.
    Aksu K; Kurt E; Alatas Ö; Gülbas Z
    Allergy Asthma Proc; 2014; 35(2):148-55. PubMed ID: 24717792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
    Pfaar O; Klimek L
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history and clinical features of aspirin-exacerbated respiratory disease.
    Fahrenholz JM
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):113-24. PubMed ID: 12668892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
    Chen JR; Buchmiller BL; Khan DA
    J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
    Makowska JS; Olszewska-Ziąber A; Bieńkiewicz B; Lewandowska-Polak A; Kurowski M; Woźniakowski B; Rotkiewicz A; Kowalski ML
    Allergy Asthma Proc; 2016 May; 37(3):216-24. PubMed ID: 27178890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period.
    Pleskow WW; Stevenson DD; Mathison DA; Simon RA; Schatz M; Zeiger RS
    J Allergy Clin Immunol; 1982 Jan; 69(1 Pt 1):11-9. PubMed ID: 7054250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs.
    Stevenson DD
    J Allergy Clin Immunol; 1984 Oct; 74(4 Pt 2):617-22. PubMed ID: 6436354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of aspirin desensitization in patients with reported aspirin allergy and cardiovascular disease.
    McMullan KL; Wedner HJ
    Clin Cardiol; 2013 Jan; 36(1):25-30. PubMed ID: 22990948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity.
    Knowles SR; Drucker AM; Weber EA; Shear NH
    Ann Pharmacother; 2007 Jul; 41(7):1191-200. PubMed ID: 17609236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin and Nonsteroidal Antiinflammatory Drugs Hypersensitivity and Management.
    Modena B; White AA; Woessner KM
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):727-749. PubMed ID: 28965637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and treatment of reactions to NSAIDs.
    Simon RA
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):189-98. PubMed ID: 12668898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salicylate pre-treatment attenuates intensity of bronchial and nasal symptoms precipitated by aspirin in aspirin-intolerant patients.
    Nizankowska E; Dworski R; Soja J; Szczeklik A
    Clin Exp Allergy; 1990 Nov; 20(6):647-52. PubMed ID: 2083404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chemotactic activity of serum granulocytes after aspirin in patients with aspirin-sensitive urticaria who find themselves in a state of tolerance for this drug].
    Grzelewska-Rzymowska I; Szmidt M; Grzegorczyk J; Rozniecki J
    Pneumonol Alergol Pol; 1993; 61(7-8):357-61. PubMed ID: 8401340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
    Waldram J; Walters K; Simon R; Woessner K; Waalen J; White A
    J Allergy Clin Immunol; 2018 Jan; 141(1):250-256. PubMed ID: 28550988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of aspirin desensitization.
    Burnett T; Katial R; Alam R
    Immunol Allergy Clin North Am; 2013 May; 33(2):223-36. PubMed ID: 23639710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishing a Safe Administration of ASA in Cardiovascular Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity with Skin and/or Respiratory Involvement.
    Al-Ahmad M; Rodriguez-Bouza T; Nurkic M
    Int Arch Allergy Immunol; 2018; 175(4):237-245. PubMed ID: 29393216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease.
    Fruth K; Pogorzelski B; Schmidtmann I; Springer J; Fennan N; Fraessdorf N; Boessert A; Schaefer D; Gosepath J; Mann WJ
    Allergy; 2013; 68(5):659-65. PubMed ID: 23464577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crossreacting drugs and chemicals.
    Woessner KM
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):149-58. PubMed ID: 12668895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin sensitivity: implications for patients with coronary artery disease.
    Gollapudi RR; Teirstein PS; Stevenson DD; Simon RA
    JAMA; 2004 Dec; 292(24):3017-23. PubMed ID: 15613671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.